MEFV mutations in systemic JIA

por Aktay Ayaz, N, Bilginer, Y, Yilmaz, E, Ergüven, M, Topaloglu, R, Bakkaloglu, A, Ozen, S
Publicado 2008

Post-synthetic benzylation of the mRNA 5′ cap via enzymatic cascade reactions

por Cornelissen, N. V., Mineikaitė, R., Erguven, M., Muthmann, N., Peters, A., Bartels, A., Rentmeister, A.
Publicado 2023

Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis

por Quartier, P, Grom, A, Ruperto, N, Brunner, HI, Schikler, K, Erguven, M, Goffin, L, Hofer, M, Kallinich, T, Marzan, K, Gaillez, C, Lheritier, K, Abrams, K, Martini, A, Lovell, DJ
Publicado 2014

PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis

por Quartier, P, Brunner, H, Constantin, T, Padeh, S, Calvo, I, Erguven, M, Goffin, L, Hofer, M, Kallinich, T, Oliveira, S, Uziel, Y, Viola, S, Nistala, K, Wouters, C, Lheritier, K, Hruska, J, Abrams, K, Martini, A, Ruperto, N, Lovell, D
Publicado 2013

Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a...

por Ruperto, N, Brunner, H, Horneff, G, Quartier, P, Constantin, T, Berkun, Y, Erguven, M, Kallinich, T, Brik, R, Wulffraat, NM, Ferrandiz, MA, Rutkowska-Sak, L, Ozdogan, H, McCann, L, Lheritier, K, Preiss, R, Tseng, L, Martini, A, Lovell, DJ
Publicado 2011